Technical Analysis for LPCN - Lipocine Inc.

Grade Last Price % Change Price Change
grade B 2.19 3.30% 0.07
LPCN closed up 3.3 percent on Tuesday, March 19, 2019, on 25 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical LPCN trend table...

Date Alert Name Type % Chg
Mar 19 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 18 Inside Day Range Contraction 3.30%
Mar 18 Wide Bands Range Expansion 3.30%
Mar 15 Calm After Storm Range Contraction -2.23%
Mar 15 Wide Bands Range Expansion -2.23%
Mar 14 Calm After Storm Range Contraction 0.00%
Mar 14 Wide Bands Range Expansion 0.00%
Mar 13 Wide Range Bar Range Expansion 7.88%
Mar 13 Upper Bollinger Band Walk Strength 7.88%

Older signals for LPCN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lipocine Inc., a specialty pharmaceutical company, is engaged in the development of pharmaceutical products in the areas of men's and women's health. The company offers a portfolio of proprietary product candidates that are used to produce pharmacokinetic characteristics; facilitate lower dosing requirements and bypass first-pass metabolism; reduce side effects; and eliminate gastrointestinal interactions that limit bioavailability. Its product candidates for men's health include LPCN 1021, an oral product candidate, which is in Phase III clinical trials; and LPCN 1111, an oral product candidate that is in Phase I/II clinical trials for the treatment of testosterone replacement therapy. The company's product candidates for women's health comprise LPCN 1107, which is in Phase I/II clinical trials for the prevention of preterm birth. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Chemistry Health Pharmaceutical Pharmaceutical Products Clinical Trial Alcohols Design Of Experiments Clinical Research Ketones Bypass Androstanes Testosterone Testosterone Replacement Therapy
Is LPCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.64
52 Week Low 1.03
Average Volume 929,923
200-Day Moving Average 1.4832
50-Day Moving Average 1.7532
20-Day Moving Average 1.9385
10-Day Moving Average 2.13
Average True Range 0.1497
ADX 41.39
+DI 32.6842
-DI 14.9341
Chandelier Exit (Long, 3 ATRs ) 2.1309
Chandelier Exit (Short, 3 ATRs ) 2.0641
Upper Bollinger Band 2.3577
Lower Bollinger Band 1.5193
Percent B (%b) 0.8
BandWidth 43.249936
MACD Line 0.1427
MACD Signal Line 0.1253
MACD Histogram 0.0175
Fundamentals Value
Market Cap 45.07 Million
Num Shares 20.6 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -2.35
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.40
Resistance 3 (R3) 2.38 2.29 2.36
Resistance 2 (R2) 2.29 2.24 2.30 2.35
Resistance 1 (R1) 2.24 2.20 2.26 2.26 2.34
Pivot Point 2.15 2.15 2.16 2.16 2.15
Support 1 (S1) 2.10 2.10 2.13 2.12 2.04
Support 2 (S2) 2.01 2.06 2.02 2.03
Support 3 (S3) 1.96 2.01 2.02
Support 4 (S4) 1.98